STRONG GROWTH IN WARM PERFUSION AND PROGRESS IN THE R&D PORTFOLIO
FIRST QUARTER 2019 (JAN - MAR)· Net sales of non-durable goods in the quarter amounted to SEK 46.8 (37.9) million, corresponding to an increase of 24 percent in SEK and 13 percent in local currency. Total net sales (incl. durable goods) in the quarter amounted to SEK 47.7 (42.5) million, corresponding to an increase of 12 percent in SEK and 3 percent in local currency. · Sales from warm perfusion represented 43 percent (35) of sales of non-durable goods. · Operating income before depreciation and amortization (EBITDA) adjusted for costs for a share-based bonus program for employees